Sudarshan Pharma Industries Ltd Multibagger Stock: In stock market, reputable companies have succeeded in providing high returns to investors over the long run.
Sudarshan Pharma Industries is one of the top. The company’s share was split in November of last year.
The company was split out of the stock market on November 5, 2024. This is why the value of the company’s shares declined from Rs 10 to one per share.
On the last trading day, the price of the share owned by the company was down by 2 percent.
IPO Came In March 2023
Sudarshan Pharma’s IPO was held in March of the year before. The company’s IPO was launched on the 9th of March 2023.
The amount of shares offered in this IPO was set in the hands of the corporation at 1600 shares. Because of this, investors were required to wager at least the amount of Rs 1,16,800.
Following the split of the shares, amount of shares held by holders who are in positions has increased to 16,000 shares.
On Friday the price of the share of the company was Rs 48.80 for each share listed on BSE.
Around two years, they invested Rs 1.16 lakh and turned it into the amount of Rs 7.80 lakh. This means that investors have made the benefit of around 7 times.
The 52-week high of the company’s shares is 53.50 rupees and the 52-week low is 5.82 rupees per share. The market capitalization of the company is Rs 1174.42 crore.
What Does The Company Do?
Sudarshan Pharma currently works separately in the pharma to the chemical and petrochemical industries.
The company sells its products to countries such as the UK, Australia, Uzbekistan, Syria, Oman, and Taiwan.
According to the information, it offers outsourcing, contract manufacturing, and provides generic formulations as well as drugs.
Quick Fact
Sudarshan Pharma Industries
| Company name | Sudarshan Pharma Industries |
|---|---|
| Share split date | November 5, 2024 |
| Share value after split | ₹1 per share |
| IPO date | March 9, 2023 |
| IPO lot size | 1600 shares |
| IPO minimum amount | ₹1,16,800 |
| Shares after split | 16,000 shares |
| Friday share price | ₹48.80 per share |
| Investor return | ₹1.16 lakh turned into ₹7.80 lakh |
| Investor gain | About 7 times |
| Business focus | Pharma, chemical, and petrochemical sectors |
| Services offered | Outsourcing, contract manufacturing |
| Products provided | Generic formulations, drugs |
| Export countries | UK, Australia, Uzbekistan, Syria, Oman, Taiwan |
Disclaimer: The website and its content are for informational purposes only and should not be considered investment advice.
